The Australian share market has recently faced a challenging period, marked by a series of declines and broader economic pressures. In such conditions, investors often look for opportunities in smaller companies that can offer both affordability and potential growth. Penny stocks, though an older term, still capture the essence of investing in emerging companies with strong financials that might provide value beyond their size.
Top 10 Penny Stocks In Australia
|
Name |
Share Price |
Market Cap |
Financial Health Rating |
|
Kinatico (ASX:KYP) |
A$0.14 |
A$60.49M |
★★★★★★ |
|
LaserBond (ASX:LBL) |
A$0.5375 |
A$63.74M |
★★★★★★ |
|
Regal Partners (ASX:RPL) |
A$2.30 |
A$845.8M |
★★★★★★ |
|
Praemium (ASX:PPS) |
A$0.68 |
A$331.48M |
★★★★★★ |
|
Ora Banda Mining (ASX:OBM) |
A$1.32 |
A$2.54B |
★★★★★★ |
|
EDU Holdings (ASX:EDU) |
A$0.83 |
A$103.04M |
★★★★★★ |
|
Integrated Research (ASX:IRI) |
A$0.295 |
A$53.27M |
★★★★★★ |
|
CTI Logistics (ASX:CLX) |
A$1.75 |
A$141.57M |
★★★★☆☆ |
|
Cogstate (ASX:CGS) |
A$2.48 |
A$423.6M |
★★★★★★ |
|
GWA Group (ASX:GWA) |
A$2.00 |
A$518.99M |
★★★★★☆ |
Click here to see the full list of 388 stocks from our ASX Penny Stocks screener.
Here we highlight a subset of our preferred stocks from the screener.
Simply Wall St Financial Health Rating: ★★★★★☆
Overview: Advanced Braking Technology Limited focuses on the research, design, development, manufacture, distribution, and sale of braking solutions globally with a market cap of A$55.72 million.
Operations: The company generates revenue of A$21.49 million from the manufacture and installation of its Failsafe wet sealed braking systems.
Market Cap: A$55.72M
Advanced Braking Technology Limited, with a market cap of A$55.72 million, has demonstrated strong financial resilience and growth potential in the penny stock space. The company reported half-year revenue of A$11.12 million, up from A$8.7 million the previous year, showcasing robust earnings growth of 133.3% over the past year and surpassing industry averages. Its interest payments are well-covered by EBIT at 23.5 times coverage, and it maintains a healthy balance sheet with more cash than total debt and short-term assets exceeding liabilities significantly. Despite these strengths, its Return on Equity remains low at 17.4%.
Simply Wall St Financial Health Rating: ★★★★☆☆
Overview: Estrella Resources Limited is involved in the exploration of mineral resources in Western Australia and Timor-Leste, with a market capitalization of A$70.74 million.
Operations: Estrella Resources Limited has not reported any revenue segments.
Market Cap: A$70.74M
Estrella Resources Limited, with a market cap of A$70.74 million, is currently pre-revenue and faces significant financial challenges. The company reported a net loss of A$21.89 million for the half-year ended December 2025, up from A$0.72 million the previous year, highlighting increased losses over time. Despite its seasoned management team and absence of long-term liabilities or debt, Estrella’s negative return on equity (-307.21%) reflects its unprofitability in the mining sector. Short-term assets (A$1.4M) exceed short-term liabilities (A$680.7K), yet it has less than a year of cash runway based on current free cash flow trends.
Simply Wall St Financial Health Rating: ★★★★★★
Overview: MGX Resources Limited, with a market cap of A$466.27 million, operates in the mining, processing, shipment, export, and sale of hematite iron ore in Australia and China.
Operations: The company’s revenue is primarily derived from Koolan Island, amounting to A$317.45 million.
Market Cap: A$466.27M
MGX Resources Limited, with a market cap of A$466.27 million, is unprofitable but maintains positive free cash flow and has a cash runway exceeding three years. The company reported half-year revenue of A$156.04 million from Koolan Island operations, despite declining sales compared to the previous year. MGX’s short-term assets significantly surpass its liabilities, ensuring financial stability without debt obligations. Although earnings have declined by 21.2% annually over five years and return on equity remains negative at -7.26%, the experienced management team may help navigate these challenges as production is expected to accelerate later in fiscal 2026.
Turning Ideas Into Actions
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include ASX:ABV ASX:ESR and ASX:MGX.
This article was originally published by Simply Wall St.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
















